Results     17-May-24
Announcements
Zydus Lifesciences consolidated net profit rises 298.62% in the March 2024 quarter
Sales rise 10.59% to Rs 5366.40 crore
Net profit of Zydus Lifesciences rose 298.62% to Rs 1182.30 crore in the quarter ended March 2024 as against Rs 296.60 crore during the previous quarter ended March 2023. Sales rose 10.59% to Rs 5366.40 crore in the quarter ended March 2024 as against Rs 4852.50 crore during the previous quarter ended March 2023.

For the full year,net profit rose 96.88% to Rs 3859.50 crore in the year ended March 2024 as against Rs 1960.30 crore during the previous year ended March 2023. Sales rose 12.70% to Rs 19021.50 crore in the year ended March 2024 as against Rs 16877.80 crore during the previous year ended March 2023.

ParticularsQuarter EndedYear Ended
 Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.
Sales5366.404852.50 11 19021.5016877.80 13
OPM %30.3825.88 -28.3122.87 -
PBDT1752.301265.70 38 5587.203916.60 43
PBT1547.001087.10 42 4823.103193.90 51
NP1182.30296.60 299 3859.501960.30 97

Previous News
  Zydus Life gets tentative USFDA nod for hypertension drugs
 ( Hot Pursuit - 14-Jun-24   12:34 )
  Sentynl receives marketing authorisation for NULIBRY® from UK MHRA
 ( Corporate News - 20-Apr-24   17:21 )
  Zydus Lifesciences launches cancer drug - IBYRA in India
 ( Corporate News - 13-Mar-24   16:31 )
  Zydus Life edges higher after launching OAB treatment drug Mirabegron in US
 ( Hot Pursuit - 22-Apr-24   09:25 )
  Zydus launches Mirabegron ER Tablets in US market
 ( Corporate News - 22-Apr-24   08:55 )
  Zydus Board approves business transfer agreement for acquisition of API biz of Sterling Biotech
 ( Corporate News - 17-Sep-24   12:04 )
  Zydus Lifesciences consolidated net profit rises 53.24% in the September 2023 quarter
 ( Results - Announcements 07-Nov-23   12:50 )
  Zydus Life launches cancer drug in India
 ( Hot Pursuit - 13-Mar-24   16:06 )
  Zydus Lifesciences to hold board meeting
 ( Corporate News - 01-Nov-23   15:54 )
  Zydus Lifesciences Ltd spurts 7.01%, up for third straight session
 ( Hot Pursuit - 12-Feb-24   13:05 )
  Zydus Lifesciences receives USFDA approval for Lacosamide Tablets
 ( Corporate News - 16-Dec-23   11:43 )
Other Stories
  Kore Foods reports standalone net loss of Rs 0.07 crore in the September 2024 quarter
  05-Oct-24   14:19
  Avantel consolidated net profit rises 42.50% in the September 2024 quarter
  05-Oct-24   13:52
  Shri Bholanath Carpets reports standalone net profit of Rs 0.02 crore in the June 2024 quarter
  30-Sep-24   07:34
  Gala Precision Engineering consolidated net profit rises 38.55% in the June 2024 quarter
  30-Sep-24   07:34
  Kross standalone net profit declines 4.25% in the June 2024 quarter
  28-Sep-24   07:36
  Jamna Auto Industries consolidated net profit rises 1.73% in the June 2024 quarter
  28-Sep-24   07:35
  Baazar Style Retail reports standalone net loss of Rs 0.39 crore in the June 2024 quarter
  26-Sep-24   07:35
  Mysore Paper Mills reports standalone net loss of Rs 22.19 crore in the June 2024 quarter
  26-Sep-24   07:35
  Educomp Solutions reports standalone net loss of Rs 1.81 crore in the June 2024 quarter
  25-Sep-24   07:30
  Ecos (India) Mobility & Hospitality consolidated net profit declines 3.08% in the June 2024 quarter
  25-Sep-24   07:30
Back Top